Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
Last updated
Summary
Product
Quetiapine 25 mg
Issue
Health products
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Quetiapine | Quetiapine 25mg | DIN 02317893 | Tablet | Quetiapine fumarate 25 mg | 35217740A |
Issue
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Wholesalers, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
| Sivem Pharmaceuticals ULC 4705 Dobrin Street, Montreal QC H4R 2P7 |
Published by
Health Canada
Audience
General public
Industry
Retail
Recall class
Type II
Identification number
RA-64532
Get notified
Receive notifications for new and updated recalls and alerts by category.